Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21024930 | 0.97 | ALDH1A1 (0.36) | ALDH1A1CTSKBCHESMN1; SMN2NPSR1 | |
| SCHEMBL23031896 | 0.95 | CTSK (0.36) | ALDH1A1CTSKBCHESMN1; SMN2NPSR1 | |
| SCHEMBL21024929 | 0.91 | CTSK (0.33) | ALDH1A1CTSKBCHESMN1; SMN2NPSR1 | |
| SCHEMBL23506490 | 0.90 | CTSK (0.32) | ALDH1A1CTSKTSHR | |
| SCHEMBL21025659 | 0.81 | CHRM5 (0.31) | CTSK | |
| SCHEMBL16489905 | 0.80 | BCHE (0.40) | ALDH1A1BCHESMN1; SMN2NPSR1 | |
| SCHEMBL21025829 | 0.78 | — | — | |
| SCHEMBL16492077 | 0.78 | BCHE (0.38) | BCHESMN1; SMN2NPSR1 | |
| SCHEMBL21397096 | 0.77 | SMN1; SMN2 (0.37) | ALDH1A1SMN1; SMN2NPSR1PDK2 | |
| SCHEMBL21025828 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190144405-A1 | Polyfunctional Oxetane-Based Compound and Production Method Thereof | CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) | 2019-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190144405-A1 | Polyfunctional Oxetane-Based Compound and Production Method Thereof | OGDH, OGFOD1, OXGR1 | ALDH1A1 763/4885CTSK 3998/4885BCHE 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.